Madbouly Khaled M, Remzi Feza H, Erkek Bulent A, Senagore Anthony J, Baeslach Christen M, Khandwala Farah, Fazio Victor W, Lavery Ian C
Department of Colorectal Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Dis Colon Rectum. 2005 Apr;48(4):711-9; discussion 719-21. doi: 10.1007/s10350-004-0666-0.
Transanal excision is an appealing treatment for low rectal cancers because of its low morbidity, mortality, and better functional results than transabdominal procedures. However, controversy exists about whether it compromises the potential for cure. Several, recent reports of high recurrence rates after local excision prompted us to review our results of transanal excision alone in patients with T1 rectal cancers.
All patients with T1 low rectal cancer undergoing local excision alone between 1980 through 1998 were reviewed for local recurrence, distant metastasis, disease-free interval, results of salvage surgery, and overall and disease-free survival. Demographics, tumor size, distance from anal verge, and preoperative endoluminal ultrasound results also were recorded. Patients with poorly differentiated tumors, perineural or lymphovascular invasion, or with mucinous component were excluded.
Fifty-two patients underwent transanal excision during the study period. Five-year recurrence was estimated to be 29.38 percent (95 percent confidence interval, 15.39-43.48). For 52 patients, five-year, cancer-specific and overall survival rates were 89 and 75 percent respectively. Fourteen of 15 patients with recurrence underwent salvage treatment with 56.2 percent (95 percent confidence interval, 35.2-90) five-year survival rate. Gender, preoperative staging by endorectal ultrasound, distance from the anal verge, tumor size, location, and T1 status discovered after transanal excision of a villous adenoma did not influence local recurrence or tumor-specific survival.
Transanal excision for T1 rectal tumors with low-grade malignancy has a high rate of recurrence. Although overall cancer survival rates might be regarded as satisfactory, this high recurrence and low salvage rate raises the issue about the role of transanal excision alone for early rectal cancer and the possible need for adjuvant therapy or increased role of resective surgery.
经肛门切除术是治疗低位直肠癌的一种有吸引力的方法,因为它的发病率、死亡率低,且与经腹手术相比功能效果更好。然而,对于它是否会影响治愈的可能性存在争议。近期有几篇关于局部切除术后高复发率的报道促使我们回顾我们对T1期直肠癌患者单纯经肛门切除术的结果。
回顾了1980年至1998年间所有仅接受局部切除的T1期低位直肠癌患者的局部复发、远处转移、无病间期、挽救性手术结果以及总生存和无病生存情况。还记录了人口统计学资料、肿瘤大小、距肛缘距离以及术前腔内超声结果。排除肿瘤分化差、有神经周围或淋巴管侵犯或有黏液成分的患者。
在研究期间,52例患者接受了经肛门切除术。估计5年复发率为29.38%(95%可信区间,15.39 - 43.48)。对于这52例患者,5年癌症特异性生存率和总生存率分别为89%和75%。15例复发患者中有14例接受了挽救性治疗,5年生存率为56.2%(95%可信区间,35.2 - 90)。性别、直肠内超声术前分期、距肛缘距离、肿瘤大小、位置以及经肛门切除绒毛状腺瘤后发现的T1状态均不影响局部复发或肿瘤特异性生存。
对低级别恶性的T1期直肠肿瘤进行经肛门切除术有较高的复发率。尽管总体癌症生存率可能被认为是令人满意的,但这种高复发率和低挽救率引发了关于单纯经肛门切除术在早期直肠癌治疗中的作用以及辅助治疗的可能需求或扩大切除性手术作用的问题。